New stroke treatment proves effective, both medically and financially

January 4, 2017 by David Orenstein  
In this illustration a clot in the brain deprives the grayed out area of blood supply. A new treatment appears cost-effective in treating the clots. National Institute of Neurological Disorders and Stroke. Credit: Brown University

As soon as possible after a stroke, a critical step is to eliminate the clot that caused it. While the current standard of care is to use "clot busting" tissue-type plasminogen activator drugs, recent studies have shown greater medical efficacy in combining the drugs with a "stent retriever" that mechanically opens the artery for a device to grab it and pull it out—a surgical procedure called "thrombectomy."

The question remained, however, of whether the added procedure was cost-effective. A new study co-authored by Theresa Shireman, professor of health services, policy and practice at the Brown University School of Public Health, found that it is. After higher initial costs, Shireman explains in the interview below, better outcomes for patients make -related care less costly in the long run.

Shireman was lead author of the study published in the journal Stroke.

To compare the cost-effectiveness of one treatment vs. another, what did you measure?

In general, new technologies or treatments in health care cost more than the existing standard of care. In cost-effectiveness analysis, the purpose is to judge the relative increase in costs against the presumably improved benefit or effect. There are occasions, however, where a new treatment provides greater benefit or effect at a lower cost. That is the case with the technology we analyzed.

How much more cost effective was treatment with the mechanical thrombectomy plus the drug than treatment with the drug alone?

In the case of the technology we assessed, it made the initial hospitalization for more expensive (the cost of actually doing the procedure) but patients improved so much in their stroke recovery that long-term costs were lower. In other words, patients' recovery with respect to physical function was so much better with stent retriever thrombectomy that they were less likely to need nursing home rehabilitation and longer . This saved money so that within 22 months, the higher procedure costs had been covered.

Does cost-effectiveness (rather than care effectiveness) matter to patients and their families or only to insurers and providers?

Cost-effectiveness should matter to all of us, as it is one approach to finding the most efficient health care interventions—those that generate the greatest benefit at the lowest cost. If we regularly find the most efficient interventions, we all will pay less for and have the best outcomes. In the case of stent retriever thrombectomy, it is easy to see the patient and family benefits, as they have better functional recovery post-stroke and are less likely to need nursing home care. That's a double-win for them and for payers and providers. In many cases, however, cost-effectiveness analyses may not generate such clear results, and not all analyses adhere to consensus guidelines.

How might these findings affect stroke treatment in the future?

For patients who suffer an ischemic stroke and are located close enough to a stroke center or hospital with the appropriately trained interventionist, access to stent retriever thrombectomy should be able to dramatically reduce the burden of stroke.

What was your role in the study?

The project was designed by Dr. David Cohen and his team at the Saint Luke's Mid-America Heart Institute in Kansas City, Missouri. I served as the lead investigator, shepherding the project through its various phases, reviewing intermediate steps, presenting the findings at an international conference and preparing the final manuscript.

Explore further: Some stroke treatments proven to reduce health care costs

More information: Theresa I. Shireman et al. Cost-Effectiveness of Solitaire Stent Retriever Thrombectomy for Acute Ischemic Stroke, Stroke (2016). DOI: 10.1161/STROKEAHA.116.014735

Related Stories

Some stroke treatments proven to reduce health care costs

July 27, 2015
Use of mechanical thrombectomy on qualifying stroke patients could result in major savings to the healthcare economy in the United Kingdom (U.K.) and other western countries with a similar healthcare structure, according ...

New study 'game-changer' for stroke treatment worldwide

February 11, 2015
A landmark study published in the New England Journal of Medicine today heralds a new era in stroke treatment across the globe.

New neuroendovascular technique shows promise in stroke patients with large-vessel clots

June 29, 2016
In an article published online April 16, 2016 by the Journal of Neurointerventional Surgery, investigators at the Medical University of South Carolina (MUSC) report promising 90-day outcomes for stroke patients with large-vessel ...

Clot removal may save money and limit disability

February 17, 2016
Adding mechanical clot removal to clot-busting drugs could lower stroke survivors medical bills, decrease government healthcare as well as non-healthcare related costs, and increase the likelihood of the patient returning ...

New devices causing 'paradigm shift' in stroke care

June 24, 2016
New devices called stent retrievers, which effectively reverse strokes, have revolutionized the treatment of certain stroke patients, according to an article in the journal Expert Review of Neurotherapeutics.

Workforce processes prior to mechanical thrombectomy vary widely, new study finds

July 26, 2016
Mechanical thrombectomy, a leading type of neurointerventional stroke treatment where a device can remove a blood clot in minutes, is essential for people experiencing a stroke, who stand to lose 2 million neurons every minute ...

Recommended for you

Could aggressive blood pressure treatments lead to kidney damage?

July 18, 2017
Aggressive combination treatments for high blood pressure that are intended to protect the kidneys may actually be damaging the organs, new research from the University of Virginia School of Medicine suggests.

Quantifying effectiveness of treatment for irregular heartbeat

July 17, 2017
In a small proof-of-concept study, researchers at Johns Hopkins report a complex mathematical method to measure electrical communications within the heart can successfully predict the effectiveness of catheter ablation, the ...

Concerns over side effects of statins stopping stroke survivors taking medication

July 17, 2017
Negative media coverage of the side effects associated with taking statins, and patients' own experiences of taking the drugs, are among the reasons cited by stroke survivors and their carers for stopping taking potentially ...

Study discovers anticoagulant drugs are being prescribed against safety advice

July 17, 2017
A study by researchers at the University of Birmingham has shown that GPs are prescribing anticoagulants to patients with an irregular heartbeat against official safety advice.

Protein may protect against heart attack

July 14, 2017
DDK3 could be used as a new therapy to stop the build-up of fatty material inside the arteries

Heart study finds faulty link between biomarkers and clinical outcomes

July 14, 2017
Surrogate endpoints (biomarkers), which are routinely used in clinical research to test new drugs, should not be trusted as the ultimate measure to approve new health interventions in cardiovascular medicine, according to ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.